These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26 related articles for article (PubMed ID: 9123579)
1. Role of humoral immunity in pancreatic islet allo- and xenograft rejection. Ahn M; Sohn C; Chang E; Chu G; DeMatteo RP; Barker CF; Markmann JF Transplant Proc; 1996 Apr; 28(2):840-1. PubMed ID: 8623428 [No Abstract] [Full Text] [Related]
2. Prolonged survival of class I deficient mouse islet allografts but not xenografts. Markmann JF; Desai NM; Bassiri H; Kim JI; Barker CF Transplant Proc; 1994 Apr; 26(2):748. PubMed ID: 8171641 [No Abstract] [Full Text] [Related]
3. Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides. Zeng Y; Torres M; Wang Y; Montag A; Thistlethwaite JR Transplant Proc; 1995 Feb; 27(1):176-7. PubMed ID: 7878961 [No Abstract] [Full Text] [Related]
4. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade. Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711 [TBL] [Abstract][Full Text] [Related]
5. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection. Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954 [TBL] [Abstract][Full Text] [Related]
6. Xenogeneic but not allogeneic pancreatic islet graft survival in recipients lacking humoral immunity and major histocompatibility complex class II antigens. Chu G; Markmann JF; Ahn M; Chang E; DeMatteo RP; Ketchum RJ; Brayman KI; Deng S; Barker CF Transplant Proc; 1997; 29(1-2):901-2. PubMed ID: 9123579 [No Abstract] [Full Text] [Related]
7. The contribution of MHC antigen modulation to islet allograft rejection. Markmann JF; Schachner MS; Bassiri H; Barker CF; Naji A Horm Metab Res Suppl; 1990; 25():104-8. PubMed ID: 2088947 [No Abstract] [Full Text] [Related]